Xuequn Bai
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems 6
- Advancements in Transdermal Drug Delivery 5
- Drug Solubulity and Delivery Systems 4
- Dermatology top 5%
-
- Nanoparticle-Based Drug Delivery 4
-
- Immunotherapy and Immune Responses 5
-
- Nanoplatforms for cancer theranostics 4
-
- Lipid Membrane Structure and Behavior 2
-
- Microencapsulation and Drying Processes 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)ACS Nano (1 paper)Acta Biomaterialia (1 paper)
- Partner nations
- ChinaUnited KingdomCanada
In The Last Decade
Xuequn Bai
16 papers receiving 401 citations
Peers
Comparison fields: 5 of 74
- Pharmaceutical Science 220
- Dermatology 86
- Biomaterials 76
- Immunology 106
- Biomedical Engineering 131
Countries citing papers authored by Xuequn Bai
This map shows the geographic impact of Xuequn Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuequn Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuequn Bai more than expected).
Fields of papers citing papers by Xuequn Bai
This network shows the impact of papers produced by Xuequn Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuequn Bai. The network helps show where Xuequn Bai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuequn Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2021 | 29 | |
| 3 | 2021 | 122 | |
| 4 | 2020 | 6 | |
| 5 | 2020 | 8 | |
| 6 | 2020 | 45 | |
| 7 | 2020 | 9 | |
| 8 | 2020 | 97 | |
| 9 | 2020 | 24 | |
| 10 | 2019 | 3 | |
| 11 | 2019 | 3 | |
| 12 | 2019 | 5 | |
| 13 | 2018 | 20 | |
| 14 | 2017 | 5 | |
| 15 | 2017 | 4 | |
| 16 | 2015 | 22 |
About Xuequn Bai
Xuequn Bai is a scholar working on Pharmaceutical Science, Biomaterials and Immunology, having authored 16 papers that have together received 404 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (6 papers), Advancements in Transdermal Drug Delivery (5 papers), Immunotherapy and Immune Responses (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Drug Solubulity and Delivery Systems (4 papers), Nanoplatforms for cancer theranostics (4 papers), Lipid Membrane Structure and Behavior (2 papers) and Microencapsulation and Drying Processes (2 papers). The work is most often cited by research in Pharmaceutical Science (220 citations), Dermatology (86 citations) and Biomaterials (76 citations). Xuequn Bai has collaborated with scholars based in China, United Kingdom and Canada. Frequent co-authors include Xin Pan, Chuanbin Wu, Guilan Quan, Minglong Chen, Peipei Yang, Wanbing Qin, Wenhao Wang, Chune Zhu, Dan Yang and Ying Sun. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.